Finance

Beta
Lists
1779:HKG
LongBio Pharma (Suzhou) Co Ltd Class H
HK$87.00
-10.49%
(-10.20) 1D
Jul 13, 4:08:39 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1779...
Open
HK$97.20
High
HK$99.95
Low
HK$86.60
Mkt. cap
6.64B
Avg. vol.
315.21K
Volume
66.85K
52-wk high
HK$165.90
52-wk low
HK$85.00
EPS
-HK$2.73
Shares outstanding
75.06M
No. of employees
85
Open
HK$97.20
High
HK$99.95
Low
HK$86.60
Mkt. cap
6.64B
Avg. vol.
315.21K
Volume
66.85K
52-wk high
HK$165.90
52-wk low
HK$85.00
EPS
-HK$2.73
Shares outstanding
75.06M
No. of employees
85
News stories
From sources across the web
About LongBio Pharma (Suzhou) Co Ltd Class H
CEO-
Employees85
Founded2020
Headquarters-
SectorBiotechnology
Websitelongbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Dec 2024
Dec 2025
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
32.10M
30.26M
Total research and development expenses
-
-
Selling, general, and admin expenses
5.14M
9.62M
Operating expense
37.29M
40.94M
Total operating expenses
37.29M
40.94M
Operating income
-37.29M
-40.94M
Other non operating income
-
-
EBT including unusual items
-44.99M
-38.01M
EBT excluding unusual items
-45.48M
-41.15M
Income tax expense
-
-
Effective tax rate
-
-
Other operating expenses
40.00K
1.07M
Net income
-44.99M
-38.01M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
411.00K
49.00K
Interest expense
-8.60M
-252.00K
Net interest expenses
-8.19M
-203.00K
Depreciation and amortization charges
-
-
EBITDA
-36.29M
-40.00M
Gain or loss from assets sale
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer